MedPath

Ultrasound- Guided Continuous Serratus Anterior Plane Block Versus Ultrasound- Guided Continuous Thoracic Paravertebral Block in Multiple Traumatic Rib Fractures.

Not Applicable
Completed
Conditions
Thoracic Paravertebral Block
Multiple Traumatic Rib Fractures
Ultrasound
Serratus Anterior Plane Block
Analgesia
Interventions
Procedure: Thoracic paravertebral block
Procedure: Serratus anterior plane block
Registration Number
NCT04710823
Lead Sponsor
Tanta University
Brief Summary

The aim of this study is to compare the analgesic efficacy of ultrasound guided continuous SAP block and ultrasound guided continuous TPVB in patients with multiple traumatic rib fractures.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Patients of either gender aged between 22-65 years with unilateral traumatic multiple fracture ribs (≥ 3 fractured ribs).
Exclusion Criteria
  • • Contraindications to regional block such as patient's refusal, coagulopathy, local infection at the site of the block, known allergy to local anesthetic drugs and spinal deformity.

    • Patients suffer from severe cardiovascular disease, hepatic or renal disease and patients with history of psychiatric illness.
    • Patients had indications for mechanical ventilation on admission or during the study period.
    • Patients had indications for immediate surgery for other associated injuries.
    • Patients with hemodynamic instability.
    • Patients having spine or pelvic fracture, traumatic brain injury, altered conscious level or spinal cord injury.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Thoracic paravertebral blockThoracic paravertebral blockPatients will receive ultrasound-guided continuous thoracic paravertebral blockusing bupivacaine 0.25% for 4 days.
Serratus anterior plane blockSerratus anterior plane blockPatients will receive ultrasound-guided continuous SAP block using bupivacaine 0.25% for 4 days.
Primary Outcome Measures
NameTimeMethod
Degree of pain scoresFour days after the block

Pain will be assessed at rest and on coughing using the VAS on a scale from 0 (no pain) to 100 (worst pain) before the block, 30 minutes, 60 minutes after the block, and then every six hours for 4 days. But in order not to interrupt the sleeping pattern of patients, patients will be considered pain free (VAS= 0) if they will be at sleep with no tachypnea, tachycardia, or hypertension.

Secondary Outcome Measures
NameTimeMethod
Changes of forced vital capacity (FVC)Four days after the block

Forced vital capacity (FVC) will be assessed using bedside spirometry before the block, 30 minutes, 60 minutes after the blocks, and then every eight hours for 4 days

Changes of forced expiratory volume in one second (FEV1)Four days after the block

Forced expiratory volume in one second (FEV1) will be assessed using bedside spirometry before the block, 30 minutes, 60 minutes after the blocks, and then every eight hours for 4 days

Incidence of complicationsFour days after the block

Incidence of respiratory complications and mechanical ventilation

Total consumption of morphineFour days after the block

Rescue analgesia will be provided with morphine (0.05 mg/kg) intravenously if visual analogue score (VAS) ≥ 40.

Changes of forced expiratory volume in one second (FEV1)/forced vital capacity (FVC)Four days after the block

FEV1/FVC ratio will be assessed using bedside spirometry before the block, 30 minutes, 60 minutes after the blocks, and then every eight hours for 4 days

Length of ICU stayFour days after the block

Length of ICU stay, defined as the time from admission to ICU to time of transfer to the surgical ward.

Length of hospital stayFour days after the block

Trial Locations

Locations (1)

Tanta University Hospitals

🇪🇬

Tanta, ElGharbiaa, Egypt

© Copyright 2025. All Rights Reserved by MedPath